Percy H. Carter's most recent trade in Blueprint Medicines Corp was a trade of 1,051 Common Stock done at an average price of $128.3 . Disclosure was reported to the exchange on July 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 128.25 per share. | 03 Jul 2025 | 1,051 | 53,155 (0%) | 0% | 128.3 | 134,791 | Common Stock |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 127.88 per share. | 03 Jun 2025 | 2,418 | 54,206 (0%) | 0% | 127.9 | 309,214 | Common Stock |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 127.88 per share. | 03 Jun 2025 | 241 | 56,624 (0%) | 0% | 127.9 | 30,819 | Common Stock |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 88.80 per share. | 05 Mar 2025 | 3,530 | 56,865 (0%) | 0% | 88.8 | 313,464 | Common Stock |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 11,000 | 60,395 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 7,500 | 49,395 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 105.13 per share. | 05 Jun 2024 | 4,000 | 41,895 (0%) | 0% | 105.1 | 420,520 | Common Stock |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 106.43 per share. | 03 Jun 2024 | 2,436 | 45,895 (0%) | 0% | 106.4 | 259,263 | Common Stock |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 90.69 per share. | 07 Mar 2024 | 2,286 | 48,331 (0%) | 0% | 90.7 | 207,317 | Common Stock |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 12,500 | 50,617 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 52.06 per share. | 05 Jun 2023 | 2,307 | 38,117 (0%) | 0% | 52.1 | 120,102 | Common Stock |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 45.72 per share. | 06 Mar 2023 | 736 | 40,449 (0%) | 0% | 45.7 | 33,650 | Common Stock |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 44.80 per share. | 06 Mar 2023 | 25 | 40,424 (0%) | 0% | 44.8 | 1,120 | Common Stock |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 12,500 | 41,185 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 59.76 per share. | 06 Jun 2022 | 1,908 | 28,685 (0%) | 0% | 59.8 | 114,022 | Common Stock |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,750 | 30,593 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Percy H. Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 39,200 | 39,200 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Percy H. Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 21,843 | 21,843 (0%) | 0% | 0 | Common Stock |